Cargando…

906. Risk of Shingles among Patients Aged 45–49 versus 50–54 Years in the US, by Immune Status

BACKGROUND: Shingles burden has historically focused on older adults, with the currently licensed vaccine in the US approved for adults aged ≥50 years. Our study aimed to estimate the incidence of shingles among adults aged 45–49 years and to ascertain whether the adjusted incidence rate (IR) was si...

Descripción completa

Detalles Bibliográficos
Autores principales: Miles, Amanda C, McGrath, Leah, Malhotra, Deepa, Welch, Verna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678037/
http://dx.doi.org/10.1093/ofid/ofad500.951